Fate Therapeutics (NASDAQ:FATE) Shares Down 5.4%

Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report)’s stock price traded down 5.4% during mid-day trading on Friday . The company traded as low as $4.73 and last traded at $4.77. 939,174 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 2,755,729 shares. The stock had previously closed […]

Related Keywords

United States ,Florida ,America , ,Fate Therapeutics Inc ,Jacobs Levy Equity Management Inc ,Needham Company ,Acadian Asset Management ,Nasdaq ,Fate Therapeutics Company Profile ,Board Of Administration Florida Retirement System ,Morgan Stanley ,Fate Therapeutics ,Get Free Report ,Forest Capital Management ,Florida Retirement System ,Asset Management ,Jacobs Levy Equity Management ,Levy Equity Management ,Fate Therapeutics Daily ,Nasdaq Fate ,Fate ,Medical ,Stocks ,Technicals ,